W Todd Penberthy

Summary

Publications

  1. ncbi Pharmacological targeting of IDO-mediated tolerance for treating autoimmune disease
    W Todd Penberthy
    University of Cincinnati, Cincinnati, OH 45237, USA
    Curr Drug Metab 8:245-66. 2007
  2. ncbi A high throughput live transparent animal bioassay to identify non-toxic small molecules or genes that regulate vertebrate fat metabolism for obesity drug development
    Kevin S Jones
    Department of Genome Science, University of Cincinnati, Cincinnati, OH, 4523, USA
    Nutr Metab (Lond) 5:23. 2008
  3. ncbi The importance of NAD in multiple sclerosis
    W Todd Penberthy
    Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati, Cincinnati, Ohio 45237, USA
    Curr Pharm Des 15:64-99. 2009

Collaborators

  • Kevin S Jones
  • Horacio L Rilo
  • Ronald J Jandacek
  • Laura A Woollett
  • Alexander P Alimov

Detail Information

Publications3

  1. ncbi Pharmacological targeting of IDO-mediated tolerance for treating autoimmune disease
    W Todd Penberthy
    University of Cincinnati, Cincinnati, OH 45237, USA
    Curr Drug Metab 8:245-66. 2007
    ..Alternatively the direct targeting of the non-redox NAD-dependent proteins using resveratrol to activate SIRT1 or PJ34 in order to inhibit PARP1 and prevent autoimmune pathogenesis are also given consideration...
  2. ncbi A high throughput live transparent animal bioassay to identify non-toxic small molecules or genes that regulate vertebrate fat metabolism for obesity drug development
    Kevin S Jones
    Department of Genome Science, University of Cincinnati, Cincinnati, OH, 4523, USA
    Nutr Metab (Lond) 5:23. 2008
    ....
  3. ncbi The importance of NAD in multiple sclerosis
    W Todd Penberthy
    Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati, Cincinnati, Ohio 45237, USA
    Curr Pharm Des 15:64-99. 2009
    ....